Advisor Group’s Kite Pharma, Inc. KITE Stock Holding History

Advisor Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-272	Closed	-$49K	–	5222
2017 Q3	$49K	Buy	272 +92	+51%	+$12.8K	﹤0.01%	2962
2017 Q2	$19K	Sell	180 -300	-63%	-$24.5K	﹤0.01%	3542
2017 Q1	$38K	Buy	480 +200	+71%	+$12.4K	﹤0.01%	2937
2016 Q4	$12K	Sell	280 -120	-30%	-$5.89K	﹤0.01%	3558
2016 Q3	$23K	Sell	400 -7	-2%	-$390	﹤0.01%	3074
2016 Q2	$19K	Buy	+407	New	+$20K	﹤0.01%	3115

Advisor Group's KITE Position: Q4 2017 in Review

Advisor Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 272 shares — an estimated $49K sold.

Advisor Group first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $49K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Advisor Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Advisor Group sold 272 Kite Pharma, Inc. shares in Q4 2017, an estimated $49K.
Advisor Group first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
Advisor Group's Kite Pharma, Inc. position peaked at $49K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.